Robert Topping

Robert Topping is an accomplished chemist with extensive experience in process development and synthetic chemistry, primarily within the pharmaceutical industry. Topping's career includes significant roles such as Associate Director and Senior Principal Scientist at Seagen, and positions at Hospira Boulder, Roche, and CordenPharma, culminating in the current role of Associate Director for Small Molecule Process Development at Pfizer. Topping holds a B.S. in Chemistry from the State University of New York at Fredonia, a Ph.D. in Chemistry from Duke University, and has completed post-doctoral research at Vanderbilt University, specializing in molecular toxicology. Throughout this career, Topping has focused on drug linkers for antibody drug conjugates and has received recognition as a Distinguished Scientist at multiple organizations.